NRIX
Nurix Therapeutics
$23.43
+$0.05 (+0.21%)Jul 27, 2026
Key metrics
The numbers that frame NRIX today
- Market cap
- $2.43B
- P/E (TTM)
- -7.1
- EV / FCF
- -8.0
- Gross margin
- 100%
- EV / Sales
- 65.9
- ROIC
- -75.5%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $8.20
- 52wk High
- $25.08
Growth
Revenue and earnings trend for NRIX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NRIX
Is Nurix Therapeutics a good buy?
Hold. Nurix Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Nurix Therapeutics is selling at a very high price.
What is the market capitalization of NRIX?
Nurix Therapeutics's market capitalization is $2.43B.
What is the P/E ratio for NRIX stock?
Nurix Therapeutics's current P/E ratio is -7.1.
What is the 52-week high for NRIX stock?
The 52-week high for Nurix Therapeutics is $25.08. The current close of $23.43 is 6.6% below that high.
What is the 52-week low for NRIX stock?
The 52-week low for Nurix Therapeutics is $8.20. The current close of $23.43 is 185.9% above that low.
Does NRIX stock pay dividends?
Nurix Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NRIX?
Nurix Therapeutics's Debt / Equity ratio is 0.14.